🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

0.5 Dropper(s) Serving Size
Other Combinations Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

RNA
Pancrealipase
Serine
Oxbile Substance
Beet
Peach
Celandine
Octacosanol
Pedra Hume Caa
Green Lipped Mussel
Alpha Glyceryl
Trace Minerals
Phosphatidic Acid
Cardiolipin
Phosphatidyl Glycerol

Other Ingredients

Water Natural Flavors Ethanol Glycerin

Label Claims — Verification

All Other
Structure/Function
All Other (98% of products) Structure/Function (89% of products) Nutrient (76% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

SHAKE WELL BEFORE USE DIRECTIONS FOR NUTRITIONAL USE: Take 1/2 dropper up to 3X per day, or as directed.

⚠️ Warnings & Precautions

KEEP AWAY FROM HEAT, SUNLIGHT AND CHILDREN

Additional Information

#881 F/12

KEEP AWAY FROM HEAT, SUNLIGHT AND CHILDREN

BIOCELL Cellular membranes are critical to optimal cellular structure and function. Vista is the culmination of Systemic Formulas' ongoing nutri-genomic and metabolomic cell membrane research. Vista is a revolutionary product supporting all aspects of cell membrane integrity. This groundbreaking formulation provides essential and unique nutrients to the mitochondria, golgi, endoplasmic and plasma membranes.

Product Details

UPC / SKU 6 35585 08811 4
DSLD Entry Date 2013-07-25
Product Type Other Combinations
Form Liquid
DSLD ID 22450
Data Updated 2026-04-11

Research Evidence

46 Research Sources
55 Avg Quality Score
23 Meta Analysis
7 Systematic Review
7 Rct
4 Clinical Trial
2 Other
1 Guideline
1 Regulatory Source
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2025
B Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Meta Analysis The Cochrane database of systematic reviews 2011
B Calcium and phosphorus supplementation of human milk for preterm infants
Systematic Review The Cochrane database of systematic reviews 2017
B Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020
B ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
Guideline Clinical nutrition (Edinburgh, Scotland) 2018
B Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Annals of palliative medicine 2022
B Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Meta Analysis The Cochrane database of systematic reviews 2015
B The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of nephrology 2022
B Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Meta Analysis Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2024
View all evidence for Phosphorus →

Compare Similar Products

View all Phosphorus products →